{"id":"maintenance-of-the-current-regimen","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This represents a clinical decision to maintain a patient's current medication regimen rather than initiate a new drug. The specific mechanism depends entirely on the drugs already being administered. This is a management strategy rather than a pharmacological intervention.","oneSentence":"Continuation of an existing therapeutic regimen without modification to maintain current clinical stability and treatment efficacy.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:53:59.777Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Maintenance therapy for unspecified chronic condition(s)"}]},"trialDetails":[{"nctId":"NCT07496528","phase":"NA","title":"Acupuncture for Colorectal sUrgery Recovery Enhancement: A Randomized Controlled Trial Evaluating Gastrointestinal Functional Recovery After Minimally Invasive Resection","status":"NOT_YET_RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2026-04-01","conditions":"Colorectal Neoplasms, Ileus Postoperative, Postoperative Complication","enrollment":240},{"nctId":"NCT03663335","phase":"PHASE2","title":"Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-11-28","conditions":"Kidney Transplantation","enrollment":418},{"nctId":"NCT05238155","phase":"","title":"Evaluation of the Impact of Reduced Immunosuppression","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2021-10-19","conditions":"Graft Vs Host Disease","enrollment":100},{"nctId":"NCT06568549","phase":"PHASE4","title":"Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-06-13","conditions":"Kidney Transplantation, Mycophenolate Mofetil","enrollment":350},{"nctId":"NCT06998524","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-06-27","conditions":"Von Willebrand Disease, Type 3","enrollment":75},{"nctId":"NCT07463235","phase":"PHASE3","title":"Safety and Potency of a High Cabergoline Dosage in Microprolactinomas","status":"RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2026-03-04","conditions":"Prolactinoma, Prolactin Excess","enrollment":70},{"nctId":"NCT07461441","phase":"PHASE3","title":"Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy","status":"RECRUITING","sponsor":"Yeungnam University College of Medicine","startDate":"2026-03-01","conditions":"Polypoidal Choroidal Vasculopathy (PCV), Age Related Macular Degeneration","enrollment":50},{"nctId":"NCT07389473","phase":"","title":"Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device","status":"RECRUITING","sponsor":"Gaize","startDate":"2024-04-17","conditions":"ADHD, Depression Disorders, Mood Disorders","enrollment":50},{"nctId":"NCT07385989","phase":"PHASE2","title":"Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"WEI XU","startDate":"2026-01-25","conditions":"Extranodal NK/T-cell Lymphoma","enrollment":40},{"nctId":"NCT06972368","phase":"NA","title":"Home-Based tDCS for Depression in BPD","status":"RECRUITING","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2026-01-01","conditions":"Major Depressive Disorder (MDD), Borderline Personality Disorders","enrollment":60},{"nctId":"NCT06910124","phase":"PHASE2","title":"Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse","status":"RECRUITING","sponsor":"Dickran Kazandjian, MD","startDate":"2025-12-02","conditions":"Multiple Myeloma","enrollment":32},{"nctId":"NCT07307443","phase":"PHASE2","title":"A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer.","status":"NOT_YET_RECRUITING","sponsor":"Zhijie Wang","startDate":"2026-02-01","conditions":"SMARCA4-Deficient Tumor, Locally Advanced or Metastatic Lung Cancer","enrollment":28},{"nctId":"NCT05114213","phase":"PHASE2","title":"MR-Guided Adaptive SBRT of Primary Tumor for Pain Control in Metastatic PDAC","status":"TERMINATED","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2021-12-15","conditions":"Pancreatic Cancer","enrollment":9},{"nctId":"NCT07246044","phase":"NA","title":"HD-tDCS for Adolescent Bipolar Depression Targeting S1","status":"RECRUITING","sponsor":"Jiangsu Province Nanjing Brain Hospital","startDate":"2025-09-16","conditions":"Adolescent, Bipolar Depression, tDCS","enrollment":100},{"nctId":"NCT05220397","phase":"PHASE3","title":"Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients","status":"TERMINATED","sponsor":"Mark Stegall","startDate":"2022-04-11","conditions":"Kidney Transplant Recipient","enrollment":468},{"nctId":"NCT07164690","phase":"PHASE2","title":"Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2025-09","conditions":"Esophageal Adenocarcinoma, Radiotherapy","enrollment":32},{"nctId":"NCT07146412","phase":"NA","title":"Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study","status":"RECRUITING","sponsor":"HudsonAlpha Institute for Biotechnology","startDate":"2025-05-02","conditions":"Cognitive Impairment, Alzheimer Blood Biomarkers, Alzheimer Disease (AD)","enrollment":200},{"nctId":"NCT07129239","phase":"PHASE3","title":"High Dose (HD) Aflibercept Switch in Neovascular Age-related Macular Degeneration (nAMD): to Load or Maintain (HEIRLOOM)","status":"NOT_YET_RECRUITING","sponsor":"Clinique de Retine de l'est","startDate":"2025-08-20","conditions":"Wet Age-related Macular Degeneration (wAMD)","enrollment":180},{"nctId":"NCT06048367","phase":"PHASE1","title":"Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor","status":"COMPLETED","sponsor":"Sichuan Enray Pharmaceutical Sciences Company","startDate":"2022-11-17","conditions":"Advanced Solid Tumor, Lung Cancer, Pancreas Cancer","enrollment":19},{"nctId":"NCT07091994","phase":"PHASE4","title":"A Prospective, Multicentre, Randomized Controlled Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy","status":"NOT_YET_RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2025-08-01","conditions":"Ischemic Stroke, Acute, Active Malignancies","enrollment":144},{"nctId":"NCT06913244","phase":"NA","title":"Long-Term Multidisciplinary Physiotherapy for Breast Cancer Survivors: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"Al Hayah University In Cairo","startDate":"2025-04-23","conditions":"Breast Cancer, Breast Cancer Female","enrollment":146},{"nctId":"NCT01152918","phase":"NA","title":"Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies","status":"COMPLETED","sponsor":"HIV Prevention Trials Network","startDate":"2010-09","conditions":"HIV Infection","enrollment":18442},{"nctId":"NCT05145283","phase":"PHASE2","title":"Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-03-16","conditions":"Acute Ischemic Stroke, Acute Renal Injury","enrollment":250},{"nctId":"NCT06838559","phase":"PHASE4","title":"Clinical Trial on 7-day Followed by Maintenance Therapy for 10 Weeks vs. 14-day and no Maintenance Course of Prednisolone for the Treatment of Infantile Epileptic Spasms Syndrome (IESS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Colombo","startDate":"2025-01-01","conditions":"Spasms, Infantile, Prednisolone","enrollment":182},{"nctId":"NCT05986773","phase":"PHASE4","title":"Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance","status":"TERMINATED","sponsor":"Stadtspital Zürich","startDate":"2023-10-10","conditions":"Acute Heart Failure, Diuretic Resistance","enrollment":13},{"nctId":"NCT06640725","phase":"PHASE2","title":"Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&N","status":"RECRUITING","sponsor":"Groupe Oncologie Radiotherapie Tete et Cou","startDate":"2025-01-02","conditions":"Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck","enrollment":70},{"nctId":"NCT04513626","phase":"PHASE2","title":"HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label","status":"RECRUITING","sponsor":"Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida","startDate":"2020-09-15","conditions":"HIV Infections","enrollment":150},{"nctId":"NCT05394779","phase":"NA","title":"DEMETRA - ADVICE-002-2022","status":"COMPLETED","sponsor":"Advice Pharma Group srl","startDate":"2022-08-23","conditions":"Obesity, Health Behavior, Life Style","enrollment":246},{"nctId":"NCT06316362","phase":"PHASE2","title":"Efficacy of SMOF Lipid in the Management of Acute Poisoning With Carbamazepine","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-01-01","conditions":"Acute Poisoning","enrollment":40},{"nctId":"NCT04233242","phase":"NA","title":"Genotype-Informed Versus Empiric Management of VirEmia","status":"COMPLETED","sponsor":"Swiss Tropical & Public Health Institute","startDate":"2020-03-03","conditions":"HIV-1-infection","enrollment":286},{"nctId":"NCT03003325","phase":"PHASE2","title":"The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV","status":"COMPLETED","sponsor":"FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS","startDate":"2017-02-02","conditions":"Polycythemia Vera","enrollment":127},{"nctId":"NCT05983211","phase":"NA","title":"Quantitative and Repetitive TMS in ALS - Recruiting for Stage 2","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2024-05-01","conditions":"Amyotrophic Lateral Sclerosis","enrollment":15},{"nctId":"NCT04320602","phase":"PHASE4","title":"Ravulizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Currently Treated With High-Dose Eculizumab","status":"COMPLETED","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2021-04-14","conditions":"Paroxysmal Nocturnal Hemoglobinuria","enrollment":18},{"nctId":"NCT06201273","phase":"NA","title":"Physical Exercise on Physiological Adaptation Capacity and Chronic Pain in Individuals With Cardiovascular Risk","status":"COMPLETED","sponsor":"Universidad San Sebastián","startDate":"2023-05-01","conditions":"Cardiometabolic Risk Factors","enrollment":192},{"nctId":"NCT03639311","phase":"PHASE2","title":"Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE Study","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2018-09-24","conditions":"HIV Infections","enrollment":97},{"nctId":"NCT06413589","phase":"PHASE2","title":"Efficacy of SMOF Lipid in the Management of Acute Poisoning With Clozapine","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-01-01","conditions":"Acute Poisoning","enrollment":40},{"nctId":"NCT03727152","phase":"PHASE3","title":"Switching From Protease Inhibitor/Ritonavir to Generic Single Tablet Regimen of Tenofovir Alafenamide/Emtricitibine/Dolutegravir","status":"COMPLETED","sponsor":"The HIV Netherlands Australia Thailand Research Collaboration","startDate":"2019-05-01","conditions":"HIV","enrollment":170},{"nctId":"NCT06249750","phase":"PHASE2","title":"Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer","status":"RECRUITING","sponsor":"Pengyuan Liu","startDate":"2024-01-01","conditions":"Metastatic Castration-resistant Prostate Cancer (CRPC)","enrollment":60},{"nctId":"NCT06212596","phase":"PHASE2","title":"Selinexor, Cyclophosphamide and Prednisone in Myeloma","status":"COMPLETED","sponsor":"University of Leeds","startDate":"2018-07-16","conditions":"Relapsed or Refractory Multiple Myeloma","enrollment":66},{"nctId":"NCT02687464","phase":"NA","title":"Appendectomy Versus Non-Operative Treatment For Acute Non-Perforated Appendicitis in Children","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2016-01-20","conditions":"Appendicitis","enrollment":978},{"nctId":"NCT02549092","phase":"PHASE3","title":"A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)","status":"COMPLETED","sponsor":"AbbVie","startDate":"2015-10-26","conditions":"Advanced Parkinson's Disease","enrollment":89},{"nctId":"NCT05498441","phase":"NA","title":"Personalized High-Definition Transcranial Direct Current Stimulation (HD-tDCS) Treatment for Major Depressive Episode","status":"UNKNOWN","sponsor":"Jiangsu Province Nanjing Brain Hospital","startDate":"2022-04-01","conditions":"Major Depressive Episode","enrollment":120},{"nctId":"NCT06065852","phase":"","title":"National Registry of Rare Kidney Diseases","status":"RECRUITING","sponsor":"UK Kidney Association","startDate":"2009-11-06","conditions":"Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis","enrollment":35000},{"nctId":"NCT02661035","phase":"PHASE2","title":"Allo HSCT Using RIC for Hematological Diseases","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2017-03-09","conditions":"Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia","enrollment":156},{"nctId":"NCT02439450","phase":"PHASE1, PHASE2","title":"A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Heat Biologics","startDate":"2015-04-15","conditions":"Non-small Cell Lung Cancer","enrollment":121},{"nctId":"NCT05902000","phase":"NA","title":"Stent Implantation Versus Balloon Dilation for Acute Anterior Circulation Tandem Occlusion","status":"UNKNOWN","sponsor":"Xueli Cai","startDate":"2023-06-14","conditions":"Thrombectomy, Tandem Occlusion, Stroke","enrollment":222},{"nctId":"NCT02850081","phase":"PHASE3","title":"Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes","status":"COMPLETED","sponsor":"Columbia University","startDate":"2017-06-01","conditions":"Carotid Artery Stenosis, Strokes","enrollment":31},{"nctId":"NCT02865850","phase":"PHASE3","title":"Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)","status":"COMPLETED","sponsor":"Akebia Therapeutics","startDate":"2016-07","conditions":"Anemia, Dialysis-Dependent Chronic Kidney Disease","enrollment":369},{"nctId":"NCT02892149","phase":"PHASE3","title":"Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD)","status":"COMPLETED","sponsor":"Akebia Therapeutics","startDate":"2016-08","conditions":"Anemia, Dialysis-Dependent Chronic Kidney Disease","enrollment":3554},{"nctId":"NCT02680574","phase":"PHASE3","title":"Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)","status":"COMPLETED","sponsor":"Akebia Therapeutics","startDate":"2016-02","conditions":"Anemia, Non-Dialysis-Dependent Chronic Kidney Disease","enrollment":1725},{"nctId":"NCT04191681","phase":"PHASE4","title":"Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2019-11-08","conditions":"Stage D Heart Failure","enrollment":50},{"nctId":"NCT00344981","phase":"NA","title":"Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2003-06","conditions":"HIV Infections, AIDS","enrollment":9},{"nctId":"NCT03752060","phase":"NA","title":"The Clinical Utility of Resistance Training for Improving Cardiovascular Disease Risk in Post-Menopausal Women","status":"COMPLETED","sponsor":"Oklahoma State University","startDate":"2019-01-15","conditions":"Cardiovascular Risk Factor, Menopause Related Conditions, Neuromuscular Function","enrollment":68},{"nctId":"NCT02065570","phase":"PHASE3","title":"Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease","status":"COMPLETED","sponsor":"AbbVie","startDate":"2014-05-01","conditions":"Crohn's Disease","enrollment":514},{"nctId":"NCT01389596","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-09-27","conditions":"Epilepsy, Partial Seizures","enrollment":295},{"nctId":"NCT02799381","phase":"PHASE3","title":"A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)","status":"COMPLETED","sponsor":"AbbVie","startDate":"2017-02-09","conditions":"Parkinson's Disease (PD)","enrollment":63},{"nctId":"NCT04257539","phase":"NA","title":"Reducing Sedentary Time in Chronic Low Back Pain: Sedentary Intervention Using Motivational Interviewing and Technology","status":"COMPLETED","sponsor":"Iowa State University","startDate":"2018-04-01","conditions":"Chronic Low-back Pain","enrollment":60},{"nctId":"NCT04360031","phase":"","title":"The Effects of Microbiota Composition on Immunosuppression Protocols in Transplantation","status":"UNKNOWN","sponsor":"Université Catholique de Louvain","startDate":"2020-02-10","conditions":"Kidney Transplant; Complications, Immunosuppression, Transplant Failure","enrollment":100},{"nctId":"NCT03160105","phase":"PHASE4","title":"Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV)","status":"COMPLETED","sponsor":"Calmy Alexandra","startDate":"2017-05-19","conditions":"HIV-1-infection, Antiretroviral Therapy, Maintenance Therapy","enrollment":186},{"nctId":"NCT03022253","phase":"PHASE3","title":"Platelet Transfusion for Treatment of Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2016-03","conditions":"Patent Ductus Arteriosus","enrollment":44},{"nctId":"NCT01636466","phase":"PHASE3","title":"The Everolimus-Transplant Exit Strategy Trial (E-TEST)","status":"TERMINATED","sponsor":"Ashtar Chami","startDate":"2013-06","conditions":"Kidney Failure, Chronic","enrollment":1},{"nctId":"NCT01798706","phase":"PHASE3","title":"Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Sanofi","startDate":"2013-06","conditions":"Type 2 Diabetes","enrollment":350},{"nctId":"NCT00491556","phase":"NA","title":"Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2007-10","conditions":"HIV Infections","enrollment":102},{"nctId":"NCT00184600","phase":"PHASE3","title":"Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":708},{"nctId":"NCT02671318","phase":"PHASE4","title":"Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence","status":"UNKNOWN","sponsor":"Hospital do Rim e Hipertensão","startDate":"2015-09","conditions":"Cytomegalovirus Infections","enrollment":250},{"nctId":"NCT00700895","phase":"PHASE3","title":"Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose","status":"UNKNOWN","sponsor":"National University Hospital, Singapore","startDate":"2006-08","conditions":"Indications for Warfarin Therapy","enrollment":320},{"nctId":"NCT00849160","phase":"PHASE3","title":"Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection.","status":"COMPLETED","sponsor":"Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida","startDate":"2009-05","conditions":"HIV-1 Infection, HIV Infections","enrollment":100},{"nctId":"NCT01101477","phase":"NA","title":"Target-Controlled Infusion of Propofol for Flexible Bronchoscopy Sedation","status":"TERMINATED","sponsor":"Chang Gung Memorial Hospital","startDate":"2010-02","conditions":"Flexible Bronchoscopy","enrollment":144},{"nctId":"NCT00323492","phase":"PHASE4","title":"TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily Truvada","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2005-09","conditions":"HIV Infections","enrollment":92}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Myfortic","Immuran"],"phase":"marketed","status":"active","brandName":"Maintenance of the current regimen","genericName":"Maintenance of the current regimen","companyName":"Hospital do Rim e Hipertensão","companyId":"hospital-do-rim-e-hipertens-o","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Continuation of an existing therapeutic regimen without modification to maintain current clinical stability and treatment efficacy. Used for Maintenance therapy for unspecified chronic condition(s).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}